Page last updated: 2024-11-04

safrole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Safrole: A member of the BENZODIOXOLES that is a constituent of several VOLATILE OILS, notably SASSAFRAS oil. It is a precursor in the synthesis of the insecticide PIPERONYL BUTOXIDE and the drug N-methyl-3,4-methylenedioxyamphetamine (MDMA). [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

safrole : A member of the class of benzodioxoles that is 1,3-benzodioxole which is substituted by an allyl group at position 5. It is found in several plants, including black pepper, cinnamon and nutmeg, and is present in several essential oils, notably that of sassafras. It has insecticidal properties and has been used as a topical antiseptic. Although not thought to pose a significant carcinogenic risk to humans, findings of weak carcinogenicity in rats have resulted in the banning of its (previously widespread) use in perfumes and soaps, and as a food additive. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
SassafrasgenusA plant genus in the LAURACEAE family. The tree bark has been used medicinally. Drinks called sarsaparilla and root beer have been prepared from Sassafras and SMILAX ORNATA (Jamaican sarsaparilla).[MeSH]LauraceaeA family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.[MeSH]

Cross-References

ID SourceID
PubMed CID5144
CHEMBL ID242273
CHEBI ID8994
SCHEMBL ID13045858
SCHEMBL ID56828
MeSH IDM0019345

Synonyms (142)

Synonym
benzene, 4-allyl-1,2-(methylenedioxy)-
DIVK1C_001022
KBIO1_001022
SDCCGMLS-0066708.P001
SPECTRUM_001446
SPECTRUM4_001939
SPECTRUM5_000843
allylcatechol methylene ether
5-allyl-1,3-benzodioxole
1,2-(methylenedioxy)-4-allylbenzene
5-(2-propenyl)-1,3-benzodioxole
1, 5-(2-propenyl)-
safrole mf
m-allylpyrocatechin methylene ether
shikimole
safrol
(allyldioxy)benzene methylene ether
wln: t56 bo do chj g2u1
shikomol
1-allyl-3,4-(methylenedioxy)benzene
[1,2-(methylenedioxy)-4-allyl]benzene
allylpyrocatechol methylene ether
safrene
3,4-(methylenedioxy)allylbenzene
4-allylpyrocatechol formaldehyde acetal
1, 5-allyl-
sassafras
nsc-11831
4-allyl-1,2-(methylenedioxy)benzene
nsc11831
IDI1_001022
BSPBIO_002810
1,3-benzodioxole, 5-(2-propenyl)-
benzene,1-allyl,3,4-methylenedioxy safrole
inchi=1/c10h10o2/c1-2-3-8-4-5-9-10(6-8)12-7-11-9/h2,4-6h,1,3,7h
NCGC00091122-01
einecs 202-345-4
3,4-methylenedioxy-allylbenzene
rcra waste no. u203
hsdb 2653
1-allyl-3,4-methylenedioxybenzene
ccris 553
4-allyl-1,2-methylenedioxybenzene
caswell no. 729
brn 0136380
1,3-benzodioxole, 5-allyl-
epa pesticide chemical code 097901
1,2-methylenedioxy-4-allylbenzene
nsc 11831
rcra waste number u203
allyldioxybenzene methylene ether
ai3-00514
benzene, 1,2-methylenedioxy-4-allyl-
safrole
94-59-7
safrole, >=97%
NCGC00091122-02
NCGC00091122-03
KBIO2_007062
KBIO3_002030
KBIO2_001926
KBIO2_004494
KBIOSS_001926
KBIOGR_002319
NINDS_001022
SPECTRUM2_000775
SPBIO_000850
SPECTRUM3_001105
SPECTRUM1503620
NCGC00091122-04
safroles
safrols
4 allyl 1,2 methylenedioxybenzene
4-allyl-1,2-methylenedioxybenzenes
shikimol
MLS001056251
smr001216599
chebi:8994 ,
CHEMBL242273
HMS503M05
HMS1922E22
5-prop-2-enyl-1,3-benzodioxole
NCGC00091122-05
NCGC00091122-06
tox21_300520
NCGC00254416-01
dtxsid0021254 ,
cas-94-59-7
NCGC00259988-01
tox21_202439
dtxcid601254
3-[(3,4-methylenedioxy)phenyl]-1-propene
4-?allyl-?1,2-?methylenedioxybenzene
5-?allyl-?1,3-?benzodioxole
AKOS016017163
1,3-benzodioxole, 5-(2-propen-1-yl)-
5-19-01-00553 (beilstein handbook reference)
unii-rsb34337v9
rsb34337v9 ,
FT-0606467
5-(prop-2-en-1-yl)-2h-1,3-benzodioxole
FS-3451
5-allylbenzo[d][1,3]dioxole
safrole [mi]
safrole [usp-rs]
m-allyl pyrocatechinmethylene ether
safrole [iarc]
SCHEMBL13045858
CCG-214763
SCHEMBL56828
3-(3,4-methylendioxyphenyl)-1-propene
5-allyl-benzo[1,3]dioxole
3-(3,4-methylenedioxyphenyl)prop-1-ene
(1,2-(methylenedioxy)-4-allyl)benzene
AC-34312
mfcd00005841
safrole, certified reference material, tracecert(r)
SR-05000002392-1
sr-05000002392
4-allyl-1,2-(methylenedioxy)benzene, 8ci
(e)5-1-propenyl]-1,3-benzodioxole
1,2-methylenedioxy-4-allyl-benzene
3,4-methylenedioxy-allybenzene
1-allyl,3,4-methylenedioxy benzene
1, 2-(methylenedioxy)-4-allylbenzene
5-(2-propenyl)-1,3-benzodioxole, 9ci
5-allyl-1,3-benzodioxolerlet ds base
4-allyl-1, 2-(methylenedioxy)benzene
3, 4-(methylenedioxy)allylbenzene
Q412424
5-allyl-benzo-1,3-dioxole
4-allyl-1,2-methylenedioxybenzene; 5-prop-2-enyl-1,3-benzodioxole
alda-89
5-allylbenzo[1,3]dioxole
safrole (usp-rs)
nci-c00362
5-(2-propen-1-yl)-1,3-benzodioxole
5-allyl-benzo(1,3)dioxole
usepa/opp pesticide code: 097901
safrol glass
safrole (iarc)
safrole, 10mg/ml in methanol

Research Excerpts

Overview

Safrole (SFL) is an IARC class 2B carcinogen. It is extracted from betel quid chewing, which is a common practice of psychoactive habits among serveral million people. Safrole is a weak hepatocarcinogen, and its carcinogenic effect has been linked to the formation of stable safrole DNA adducts.

ExcerptReferenceRelevance
"Safrole (SFL) is an IARC class 2B carcinogen. "( Formation of RNA adducts resulting from metabolic activation of spice ingredient safrole mediated by P450 enzymes and sulfotransferases.
Gong, B; Li, W; Liao, Y; Liu, Y; Peng, Y; Ran, G; Tan, R; Wang, X; Wu, C; Zhang, S; Zheng, J, 2023
)
2.58
"Safrole is a natural compound categorized as a group 2B carcinogen extracted from betel quid chewing, which is a common practice of psychoactive habits integrated into social and cultural ceremonies among serveral million people, especially in Southern or Southeastern Asia. "( Safrole induced cytotoxicity, DNA damage, and apoptosis in macrophages via reactive oxygen species generation and Akt phosphorylation.
Chen, CH; Chen, CJ; Chen, WY; Chian, CY; Chien, KJ; Horng, CT; Kuan, YH; Lin, ML; Su, CH; Tsai, PK; Yang, ML; Yeh, CH, 2018
)
3.37
"1. Safrole is a natural compound categorized as a group 2B carcinogen extracted from sassafras oil or certain other essential oils. "( Cytotoxicity of safrole in HepaRG cells: studies on the role of CYP1A2-mediated ortho-quinone metabolic activation.
He, J; Hu, L; Shao, H; Song, Y; Wu, F; Zhong, L, 2019
)
1.48
"Safrole is a carcinogen found in plants. "( The Mechanism of Safrole-Induced [Ca²⁺]i Rises and Non-Ca²⁺-Triggered Cell Death in SCM1 Human Gastric Cancer Cells.
Cheng, JS; Chou, CT; Fang, YC; Ho, CM; Hung, TY; Jan, CR; Kuo, CC; Kuo, DH; Li, YD; Liang, WZ; Lin, JR; Shieh, P; Sun, TK, 2015
)
2.2
"Safrole is a documented rodent hepatocarcinogen, yet its hepatocarcinogenic potential in human is not known."( Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing.
Chan, SA; Chen, CL; Chi, CW; Chung, YT; Liu, TY; Wu, CC, 2008
)
2.51
"Safrole is a natural plant constituent, found in sassafras oil and certain other essential oils. "( Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation.
Chi, CW; Don, MJ; Ho, LK; Hsieh, CH; Ueng, YF, 2004
)
2
"Safrole is a weak hepatocarcinogen, and its carcinogenic effect has been linked to the formation of stable safrole DNA adducts. "( Safrole-induced oxidative damage in the liver of Sprague-Dawley rats.
Chen, CC; Chen, CL; Chi, CW; Liu, TY, 1999
)
3.19
"Safrole is a known rodent hepatocarcinogen, yet its carcinogenicity in human beings is largely undetermined."( Safrole-like DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history.
Chang, KW; Chen, CL; Chi, CW; Liu, TY, 1999
)
2.47
"Isosafrole is a mixed-type inducer, inducing P-450b, P-450c, and P-450d."( Induction of specific cytochrome P-450 isozymes by methylenedioxyphenyl compounds and antagonism by 3-methylcholanthrene.
Goldstein, JA; Hodgson, E; Linko, P; Yeowell, HN, 1985
)
0.78

Effects

ExcerptReferenceRelevance
"Like safrole, which has been shown to be nonmutagenic with the Ames assay, eugenol and methyleugenol were found to be nonmutagenic with the Ames assay."( Safrole, eugenol and methyleugenol induce intrachromosomal recombination in yeast.
Chan, WS; Gietz, RD; Hastings, PJ; Mehta, RD; Schiestl, RH, 1989
)
2.17

Actions

ExcerptReferenceRelevance
"Isosafrole did, however, increase amphetamine elimination along with urine volume."( Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
Law, MY; Moody, DE; Slawson, MH, 2000
)
0.82

Treatment

Isosafrole pretreatment does not induce aryl hydrocarbon hydroxylase activity ("cytochrome P1-450") in C57BL/6N or DBA/2N mice. It induces acetanilide 4-hydroxylases activity more than 3-fold in both strains. Isosaf role or 3-MC treatment had little effect on testosterone metabolism or pentoxyresorufin O-dealkyl enzyme activity.

ExcerptReferenceRelevance
"Isosafrole pretreatment does not induce aryl hydrocarbon hydroxylase activity ("cytochrome P1-450") in C57BL/6N or DBA/2N mice, induces acetanilide 4-hydroxylase activity ("cytochrome P3-450") more than 3-fold in C57BL/6N but not in DBA/2N mice, and induces isosafrole metabolite formation more than 3-fold in both C57BL/6N and DBA/2N mice."( Isosafrole-induced cytochrome P2-450 in DBA/2N mouse liver. Characterization and genetic control of induction.
Nebert, DW; Negishi, M; Ohyama, T, 1984
)
1.4
"Isosafrole treatment of the animals only slightly increased the activating capacity, but particularly with microsomes from the DBA/2N strain, displacement of the putative inhibitory isosafrole metabolite greatly increased their activating capacity."( Effects of enzyme induction on the distribution of the food carcinogen 2-amino-3,8-dimethyl-imidazo[4,5-ss]-quinoxaline (MeIQx) in Ah-receptor- responsive- and Ah-receptor-non-responsive mice.
Alexander, J; Ingebrigtsen, K; Klungsøyr, L; Vikse, R, 1995
)
0.81
"Isosafrole or 3-MC treatment had little effect on testosterone metabolism or pentoxyresorufin O-dealkylase activity in either strain, while 3-MC induced ethoxyresorufin O-deethylase activity in C57BL/6J but not DBA/2NCR mice."( Effects of cytochrome P-450 monooxygenase inducers on mouse hepatic microsomal metabolism of testosterone and alkoxyresorufins.
Kelley, M; Safe, S; Womack, J, 1990
)
0.79
"Isosafrole treatment (75 mg/kg X 3 days) increased the total hepatic microsomal cytochrome P-450 content to the same extent in the two congenic strains."( Induction of cytochrome P-450 in congenic C57BL/6J mice by isosafrole: lack of correlation with the Ah locus.
Cook, JC; Hodgson, E, 1986
)
1.03
"Isosafrole pretreatment (ISO; 150 mg/kg, i.p., X 3 days) elevated the rate by almost 2-fold in each species."( Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
Gessner, T; Olson, JR; Wroblewski, VJ, 1988
)
0.79

Toxicity

ExcerptReferenceRelevance
" Moreover, molinate is metabolized readily by both liver and testis microsomal enzymes, suggesting that the molinate toxic metabolite could be formed in the testis in close proximity to its site of action."( Testicular toxicity of molinate in the rat: metabolic activation via sulfoxidation.
Hess, RA; Jewell, WT; Miller, MG, 1998
)
0.3
" HC at a weakly toxic level (0."( Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes.
Ishii, H; Nakagawa, Y; Nakajima, K; Ogata, A; Suzuki, T, 2009
)
0.58

Pharmacokinetics

ExcerptReferenceRelevance
" The developed assay was applied to a pharmacokinetic study in humans."( Development and validation of a highly sensitive LC-MS/MS method for simultaneous quantitation of ethionamide and ethionamide sulfoxide in human plasma: application to a human pharmacokinetic study.
Deshpande, AY; Gurav, S; Kulkarni, R; Mullangi, R; Mungantiwar, A; Pandey, S; Punde, R; Zambre, V, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" The greatest difference between in vivo and in vitro absorption values occurred with safrole, which was the least well absorbed and the most volatile compound."( Comparison of percutaneous absorption of fragrances by humans and monkeys.
Anderson, J; Bronaugh, RL; Bucks, D; Mailbach, HI; Stewart, RF; Wester, RC, 1985
)
0.49

Dosage Studied

No DNA damage was detected in stomach, nor was MN elevated in peripheral blood following dosing with safrole suggesting that, as far both safrole and estragole, oxidative damage may contribute to genotoxicity.

ExcerptRelevanceReference
" The non-linear dose-response curves for genotoxicity obtained with the allylbenzenes and their 1'-hydroxy metabolites indicate that it is important to consider dose-dependence in metabolism when interpreting the significance to humans of animal data obtained with very high doses of the compounds studied."( Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Caldwell, J; Chan, VS, 1992
)
0.28
" The profiles of isoenzymes induced in vitro were compared with those induced in liver microsomes of rats dosed with the same agents."( Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry.
Bars, RG; Elcombe, CR; Mitchell, AM; Wolf, CR, 1989
)
0.28
"A liquid chromatographic method is described for determination of perphenazine and perphenazine sulfoxide in representative dosage forms."( Liquid chromatographic method for perphenazine and its sulfoxide in pharmaceutical dosage forms for determination of stability.
Beaulieu, N; Lovering, EG,
)
0.13
"8% of the dose being excreted in the bile over a 5- to 8-hr collection period 0 or 24 hr after iv dosing (1, 10, or 100 nmol/kg) and 72 hr after oral dosing (100 nmol/kg)."( Effect of dose, time, and pretreatment on the biliary excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
Andersen, ME; Birnbaum, LS; Kedderis, LB, 1993
)
0.29
"Regulation of cytochrome P-450 isozymes 1a-1, 1a-2, and 2b-10 by methylenedioxyphenyl compounds was studied by measuring levels of mRNA, protein, and enzyme activity in hepatic tissue from C57BL/6 (Ah+) and DBA/2 (Ah-) mice dosed with isosafrole (ISO) or piperonyl butoxide (PBO)."( Regulation of cytochrome P-450 isozymes by methylenedioxyphenyl compounds.
Adams, NH; Hodgson, E; Levi, PE, 1993
)
0.47
" The validity of the method was demonstrated by a linear dose-response relationship observed in rats given oral doses of safrole at 30, 75, and 150 mg/kg body weight."( Biological monitoring of environment exposure to safrole and the Taiwanese betel quid chewing.
Chang, MJ; Hsieh, LL; Ko, CY; Lin, RF, 2002
)
0.78
" Dosing safrole at 50mg/kg body weight and malabaricone C-containing mace extract at a ratio reflecting the relative presence in mace, and assuming 100% or 1% uptake of malabaricone C-containing mace extract, the model predicted inhibition of 1'-sulfooxysafrole formation for rats and humans by 90% and 100% or 61% and 91%, respectively."( Malabaricone C-containing mace extract inhibits safrole bioactivation and DNA adduct formation both in vitro and in vivo.
Boonpawa, R; Martati, E; Paini, A; Punt, A; Rietjens, IM; Spenkelink, A; van Bladeren, PJ; van den Berg, JH; Vervoort, J, 2014
)
1.09
" No DNA damage was detected in stomach, nor was MN elevated in peripheral blood following dosing with safrole suggesting that, as far both safrole and estragole, oxidative damage may contribute to genotoxicity."( In vivo genotoxicity of estragole in male F344 rats.
Bishop, ME; Davis, KJ; Ding, W; Duan, JD; Jeffrey, AM; Levy, DD; Lyn-Cook, LE; Manjanatha, MG; Pearce, MG; White, GA; Williams, GM, 2015
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
flavouring agentA food additive that is used to added improve the taste or odour of a food.
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzodioxoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency2.74170.000714.592883.7951AID1259369
Microtubule-associated protein tauHomo sapiens (human)Potency0.07080.180013.557439.8107AID1460
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency43.45320.013326.981070.7614AID1346978
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency28.18380.000214.376460.0339AID588532
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency61.78650.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency61.37930.005428.02631,258.9301AID1346982
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency49.18800.023723.228263.5986AID743223
caspase-3Homo sapiens (human)Potency43.45320.013326.981070.7614AID1346978
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency25.87680.000323.4451159.6830AID743065; AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency34.37620.000627.21521,122.0200AID651741
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency3.16230.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)10.00000.00011.774010.0000AID625245
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (24)

Processvia Protein(s)Taxonomy
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (36)

Assay IDTitleYearJournalArticle
AID290035Antimitotic effect in Lytechinus variegatus at first cleavage stage at 100 ug/mL2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID334991Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID290036Antimitotic effect in Lytechinus variegatus at third cleavage stage at 10 ug/mL2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID290031Cytotoxicity against HCT8 cells2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID290033Cytotoxicity against SF295 cells2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID334989Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334996Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334997Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1272741Cytotoxicity against human HL60 cells after 48 hrs by CCK8 assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Antileukemic activity of lignans and phenylpropanoids of Cinnamomum parthenoxylon.
AID334994Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID337836Antifungal activity against Candida albicans ATCC 18804 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID290030Cytotoxicity against HL60 cells2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID334995Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334990Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID334993Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID335000Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1112517Toxicity to Musca domestica (house fly) applied to pronotum assessed as compound level per fly causing insect mortality measured after 24 hr2012Pest management science, Aug, Volume: 68, Issue:8
Quantitative structure-activity relationships of monoterpenoid binding activities to the housefly GABA receptor.
AID337837Antifungal activity against Pityrosporum ovale ATCC 14521 after 3 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID334992Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1112518Displacement of [3H]TBOB binding to GABA receptor in Musca domestica (house fly) heads homogenates assessed as [3H]TBOB binding at 500 uM incubated for 90 min by scintillation counting method2012Pest management science, Aug, Volume: 68, Issue:8
Quantitative structure-activity relationships of monoterpenoid binding activities to the housefly GABA receptor.
AID290038Antimitotic effect in Lytechinus variegatus at blastulae stage at 10 ug/mL2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID290039Antimitotic effect in Lytechinus variegatus at blastulae stage at 100 ug/mL2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID290032Cytotoxicity against MDA-MB-435 cells2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID1272742Cytotoxicity against human U937 cells after 48 hrs by CCK8 assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Antileukemic activity of lignans and phenylpropanoids of Cinnamomum parthenoxylon.
AID290037Antimitotic effect in Lytechinus variegatus at third cleavage stage at 100 ug/mL2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID334999Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334998Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID337835Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID290034Antimitotic effect in Lytechinus variegatus at first cleavage stage at 10 ug/mL2007European journal of medicinal chemistry, Mar, Volume: 42, Issue:3
Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (600)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990199 (33.17)18.7374
1990's92 (15.33)18.2507
2000's121 (20.17)29.6817
2010's152 (25.33)24.3611
2020's36 (6.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 61.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index61.73 (24.57)
Research Supply Index6.43 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index107.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (61.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.32%)5.53%
Reviews29 (4.69%)6.00%
Case Studies5 (0.81%)4.05%
Observational0 (0.00%)0.25%
Other582 (94.17%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]